Key facts
- It has raised $1.5M; the latest was Angel (individual) ($1.5M) in Mar 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Probeland
- ·The full record, as it builds
Funding rounds
No funding rounds for Probeland are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Probeland
Manufacturer of probiotic raw materials and biotechnology products designed to develop microorganisms and bioactive compounds for health and industrial applications. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- South Korea
- Ownership
- Privately Held (backing)
Probeland doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Probeland shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Probeland in its N-PORT filings yet. We sweep new filings monthly.